Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H.B. Fuller CoFRA:HB1 72 Debt-to-EBITDA is 3.03 as of May. 2026, which is 26% below its 10-year median of 4.08. GuruFocus rates FRA:HB1 with a GF Score™ of 72/100 and a GF Value™ of €57.02. The stock has 6 warning signs investors should review. Among 1,242 Chemicals companies, H.B. Fuller Co ranks worse than 67.07% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for H.B. Fuller Co's Debt-to-EBITDA or its related term are showing as below:
FRA:HB1'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.62 Med: 4.08 Max: 12.8
Current: 3.71
During the past 13 years, the highest Debt-to-EBITDA Ratio of H.B. Fuller Co was 12.80. The lowest was 2.62. And the median was 4.08.
FRA:HB1's Debt-to-EBITDA is ranked worse than 67.07% of 1242
companies
in the Chemicals industry
Industry Median: 2.15
vs FRA:HB1: 3.71
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
H.B. Fuller Co Debt-to-EBITDA Related Terms
H.B. Fuller Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for H.B. Fuller Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:HB1 vs ASH, HWKN, WDFC: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, H.B. Fuller Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H.B. Fuller Co Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, H.B. Fuller Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where H.B. Fuller Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (May. 2026) EBITDA data.
H.B. Fuller Co (FRA:HB1) has a Debt-to-EBITDA of 3.03 as of May. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on H.B. Fuller Co. This is 26% below median its historical median of 4.08. Over the past decade, H.B. Fuller Co's Debt-to-EBITDA has ranged from 2.62 to 12.80. According to the industry distribution chart, H.B. Fuller Co ranks #833 out of 1242 companies in the Chemicals industry, placing it in the top 67.1%.
Is H.B. Fuller Co's Debt-to-EBITDA too high?
H.B. Fuller Co's current Debt-to-EBITDA of 3.03 is 26% below median its 10-year median of 4.08. Over the past 10 years, this metric has ranged from a low of 2.62 to a high of 12.80. The Chemicals industry median Debt-to-EBITDA is 2.15. H.B. Fuller Co's value of 3.03 is 40.9% above this industry median. Based on the distribution chart, H.B. Fuller Co ranks #833 out of 1242 companies in the Chemicals industry, which is below the industry midpoint. Overall, H.B. Fuller Co has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does H.B. Fuller Co's Debt-to-EBITDA compare to ASH and HWKN?
According to the Chemicals industry distribution chart, H.B. Fuller Co ranks #833 out of 1242 companies for Debt-to-EBITDA. This places H.B. Fuller Co in the lower half of its industry. The industry median Debt-to-EBITDA is 2.15. H.B. Fuller Co's value of 3.03 is 40.9% above this benchmark. Historically, H.B. Fuller Co's own Debt-to-EBITDA has ranged from 2.62 to 12.80 over the past decade. While the company's 10-year median is 4.08 vs. the industry median of 2.15, H.B. Fuller Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.15, based on 1,242 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H.B. Fuller Co's current Debt-to-EBITDA of 3.03 is 40.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on H.B. Fuller Co. For the Chemicals industry, the median Debt-to-EBITDA is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H.B. Fuller Co's current Debt-to-EBITDA is 3.03, which is 26% below median its own 10-year median of 4.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H.B. Fuller Co stock overvalued right now?
H.B. Fuller Co (FRA:HB1) has a current Debt-to-EBITDA of 3.03. The stock's GF Value™ is €57.02, compared to a current price of €52.50 — trading 7.9% below its estimated fair value. The current Debt-to-EBITDA is 3.03, which is 26% below median its 10-year median of 4.08 and 40.9% above the Chemicals industry median of 2.15. H.B. Fuller Co's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For H.B. Fuller Co (FRA:HB1), the current Debt-to-EBITDA is 3.03 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H.B. Fuller Co (FRA:HB1) Overvalued in 2026?
Based on GuruFocus' analysis, H.B. Fuller Co stock appears to be undervalued.
The current stock price of €52.50 is trading 7.9% below its estimated GF Value™ of €57.02.
Key valuation signals for FRA:HB1:
Debt-to-EBITDA: 3.03 (26% below median its 10-year median of 4.08)
GF Value™: €57.02 vs. price of €52.50 (7.9% below fair value)
Industry Position: 40.9% above the Chemicals median (#833 of 1242)
No single metric tells the full story. See the FRA:HB1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
72GF Score
Get the complete analysis for FRA:HB1
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HB1 has been successfully added to your 
